Double Targeting Ligands to Identify and Treat Prostate Cancer
Friday, September 15, 2017
John Babich, PhD, and collaborators have demonstrated a new way to identify and localize prostate cancer tumors while protecting healthy tissue and reducing side effects. Read the featured basic article of the September issue of The Journal of Nuclear Medicine.
